Beta blockade in the post-myocardial infarction setting: pharmacologic rationale and clinical evidence.

Preventive cardiology

Volumn 9, Issue 2, 2006, Pages 96-101

  Williams, Randall E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HEART ARRHYTHMIA; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; ARRHYTHMIA; EVIDENCE-BASED MEDICINE; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33745363910     PISSN: 1520037X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1520-037X.2006.04690.x     Document Type: Review

References (31)